Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Melanated Group Midwifery Care (MGMC) (MGMC)

5. oktober 2026 opdateret af: Kylea Laina Liese, University of Illinois Chicago

Sorte jordemødre til sorte kvinder: Barselspleje for at forbedre tilliden og dæmpe strukturel racisme

This study is being conducted to determine if a multi-level intervention for delivering maternity care can improve patient trust and engagement among Black birthing people.

Studieoversigt

Status

Aktiv, ikke rekrutterende

Detaljeret beskrivelse

Low-risk pregnant participants will be randomized into Melanated Group Midwifery Care or usual individualized obstetric care. In Melanated Group Midwifery Care (MGMC), Black women will receive prenatal care from a Black midwife in groups with the same 8-10 other Black women throughout pregnancy. In pregnancy and into the first year postpartum, MGMC patients will stay connected to the health system through a proactive care coordinator, who is a Black licensed nurse. For the first year after giving birth, patients in MGMC will also be supported by a trained postpartum doula.

All participants (intervention and usual care groups) will complete study measures that include validated surveys on patient trust, respect and engagement at 6 time points:

  • 3 time points in pregnancy [baseline (<20 weeks), 26-28 weeks, and 35- 37 weeks] and
  • 3 in the postpartum at 2-, 6-, and 12-months
  • Additional qualitative interviews will be done to track the care received by medically and socially complex patients, including all who experience a severe maternal morbidity.

The investigators will also document how MGMC gets embedded in practice through a qualitative process evaluation.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

432

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Illinois
      • Chicago, Illinois, Forenede Stater, 60612-7316
        • University of Illinois at Chicago

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

15 år til 49 år (Barn, Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Inclusion criteria for patients:

  • pregnant women who self-identify as Black on a standard prenatal intake form
  • less than 20 weeks pregnant
  • 15 years old or older
  • present to the general obstetrics group at the University of Chicago Medical Center for their new prenatal visit
  • speak and understand English

Inclusion criteria for providers:

• All black midwives, care coordinators, and community postpartum doulas at the University of Chicago are eligible to participate.

Exclusion criteria for patients:

  • having a condition for which they present to a higher level of obstetrics care (e.g., maternal fetal medicine) for their new prenatal visit
  • having a cognitive issue that impairs their ability to give informed consent.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Sundhedstjenesteforskning
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: MGMC Intervention Group

In the MGMC (intervention) group, pregnant women will participate in group prenatal care and have ~2-hour visits with the same two co-facilitators, a Black midwife and a Black care coordinator, along with 8-12 other Black women at a similar stage of pregnancy, for all prenatal and one postnatal care visits.

The care coordinator will proactively engage with women throughout pregnancy and up to 12 months postpartum. The care coordinator helps women make appointments, sends reminders, and follows-up to ensure care was received, understood, and was appropriate. In the 3rd trimester, women in MGMC will be introduced to a community-based postpartum doula. The doula will make home visits once before birth and within the first 2 weeks postpartum; they will have approximately 50 contact hours available for 12 months postpartum for primarily in-person support, but they will be available by phone and text.

Racially concordant maternity care Group prenatal care Racially concordant nursing care coordination Postpartum doula support

Ingen indgriben: Usual Care

In the usual care (comparator) group, pregnant women attend individually scheduled visits with a midwife or obstetrician for a physical assessment and counseling. Although this can vary by provider, continuity of care is rare and racial concordance is not a consideration. Referrals for medical or social services are given to the patient to complete in both prenatal and postnatal care.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Patient Engagement-Prenatal Adequacy
Tidsramme: Birth (T3)

Appropriate number (yes/no) and timing of prenatal visits (yes/no) documented in electronic medical records

Birth (T3)
Patient Engagement-Prenatal Adherence
Tidsramme: Birth (T3)

Five tests completed during prenatal period (yes/no), documented in electronic medical record

Birth (T3)
Patient Engagement-Postnatal adequacy
Tidsramme: 1 year postpartum (T6)

Appropriate number (yes/no) and timing of postnatal visits (yes/no) documented in electronic medical record

1 year postpartum (T6)

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Patient activation
Tidsramme: Change from baseline through 12 months postpartum (T6)

Patient Activation Measure (PAM), 13-item scale, range 0-100, Likert disagree strongly to agree strongly and not applicable. Assesses degree to which individuals take an active role in managing health and health care. Higher scores are more likely to understand that their active involvement is critical to their state of health and considered more ''in charge.'' The PAM has strong psychometric properties and is predictive of a wide range of health-related behaviors. Hibbard et al. report that a 4-point difference in PAM scores can be viewed as clinically significant.

Change from baseline through 12 months postpartum (T6)
Patient Autonomy
Tidsramme: Change from baseline through 12 months postpartum (T6)

Mothers Autonomy in Decision-Making Scale. 7 item scale, Likert completely disagree to completely agree. Assesses the degree to which patients were given decision-making for healthcare decisions, and if patients felt respected by providers. Higher scores indicate that providers supported patient autonomy and patient decision-making.

Change from baseline through 12 months postpartum (T6)
Provider Trust
Tidsramme: Change from baseline through 12 months postpartum (T6)

Trust in Physician Scale, 11 items, range 11-55, Likert 1-5; α =0.85-0.90.

Change from baseline through 12 months postpartum (T6)
Patient Satisfaction
Tidsramme: Change from late pregnancy (35-37 gestational weeks) (T3) and 2 months postpartum (T4)

22 items; 5-point Likert (excellent to poor); α =0.95. Excellent reliability and construct validity, taps six established dimensions of satisfaction (art of care, technical quality, access, physical environment, availability, and efficacy)

Change from late pregnancy (35-37 gestational weeks) (T3) and 2 months postpartum (T4)
Mental Well Being
Tidsramme: Change from baseline through 12 months postpartum (T6)

Computerized Adaptive Testing - Mental Health: assessing depression, anxiety, suicidality, substance use disorder, and social determinants of health.

Change from baseline through 12 months postpartum (T6)
Respectful Care
Tidsramme: Change from late pregnancy (35-37 gestational weeks) (T3) and 2 months postpartum (T4)

Mothers on Respect index (MORi) quantifies women's sense of disrespect and dismissal when engaging in conversation with providers, 14 items, Likert, ranging from 1-strongly disagree to 6-strongly agree. α =0.94

Change from late pregnancy (35-37 gestational weeks) (T3) and 2 months postpartum (T4)

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Medical Referrals
Tidsramme: 12 months postpartum (T6)

Referrals to higher acuity medical or obstetric care

12 months postpartum (T6)
Social Referrals
Tidsramme: 12 months postpartum (T^)

Referrals to higher acuity mental health or social services

12 months postpartum (T^)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Stacie L Geller, PhD, University of Illinois Chicago

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

8. juni 2022

Primær færdiggørelse (Anslået)

15. januar 2027

Studieafslutning (Anslået)

1. august 2027

Datoer for studieregistrering

Først indsendt

26. april 2022

Først indsendt, der opfyldte QC-kriterier

3. maj 2022

Først opslået (Faktiske)

9. maj 2022

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

6. oktober 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

5. oktober 2026

Sidst verificeret

1. oktober 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • CHAIRb 21120101
  • AD-2020C3-21229 (Andet bevillings-/finansieringsnummer: PCORI Foundation)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner